Hyperparathyroidism Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
Conditions:   Postmenopausal Osteoporosis;   Hypovitaminosis D;   Hyperparathyroidism Interventions:   Drug: Risedronate;   Drug: Vitamin D Sponsors:   Hospital Regional 1o de Octubre;   National Polytechnic Institute, Mexico;   Universidad Nacional Autonoma de Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
Conditions:   Postmenopausal Osteoporosis;   Postmenopause;   Hyperparathyroidism, Secondary;   Hypovitaminosis D;   Hyperparathyroidism, Primary Intervention:   Drug: Cholecalciferol Sponsors:   Hospital Regional 1o de Octubre;   Universidad Nacional Autonoma de Mexico;   National Polytechnic Institute, Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
Conditions:   Postmenopausal Osteoporosis;   Hypovitaminosis D;   Hyperparathyroidism Interventions:   Drug: Risedronate;   Drug: Vitamin D Sponsors:   Hospital Regional 1o de Octubre;   National Polytechnic Institute, Mexico;   Universidad Nacional Autonoma de Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
Conditions:   Postmenopausal Osteoporosis;   Postmenopause;   Hyperparathyroidism, Secondary;   Hypovitaminosis D;   Hyperparathyroidism, Primary Intervention:   Drug: Cholecalciferol Sponsors:   Hospital Regional 1o de Octubre;   Universidad Nacional Autonoma de Mexico;   National Polytechnic Institute, Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
Conditions:   Postmenopausal Osteoporosis;   Hypovitaminosis D;   Hyperparathyroidism Interventions:   Drug: Risedronate;   Drug: Vitamin D Sponsors:   Hospital Regional 1o de Octubre;   National Polytechnic Institute, Mexico;   Universidad Nacional Autonoma de Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
Conditions:   Postmenopausal Osteoporosis;   Postmenopause;   Hyperparathyroidism, Secondary;   Hypovitaminosis D;   Hyperparathyroidism, Primary Intervention:   Drug: Cholecalciferol Sponsors:   Hospital Regional 1o de Octubre;   Universidad Nacional Autonoma de Mexico;   National Polytechnic Institute, Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
Conditions:   Postmenopausal Osteoporosis;   Hypovitaminosis D;   Hyperparathyroidism Interventions:   Drug: Risedronate;   Drug: Vitamin D Sponsors:   Hospital Regional 1o de Octubre;   National Polytechnic Institute, Mexico;   Universidad Nacional Autonoma de Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
Conditions:   Postmenopausal Osteoporosis;   Postmenopause;   Hyperparathyroidism, Secondary;   Hypovitaminosis D;   Hyperparathyroidism, Primary Intervention:   Drug: Cholecalciferol Sponsors:   Hospital Regional 1o de Octubre;   Universidad Nacional Autonoma de Mexico;   National Polytechnic Institute, Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
Conditions:   Postmenopausal Osteoporosis;   Hypovitaminosis D;   Hyperparathyroidism Interventions:   Drug: Risedronate;   Drug: Vitamin D Sponsors:   Hospital Regional 1o de Octubre;   National Polytechnic Institute, Mexico;   Universidad Nacional Autonoma de Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
Conditions:   Postmenopausal Osteoporosis;   Postmenopause;   Hyperparathyroidism, Secondary;   Hypovitaminosis D;   Hyperparathyroidism, Primary Intervention:   Drug: Cholecalciferol Sponsors:   Hospital Regional 1o de Octubre;   Universidad Nacional Autonoma de Mexico;   National Polytechnic Institute, Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials